[{"Assets_0_FY_USD":3546014000.0,"CommonStockSharesOutstanding_0_FY_shares":253253362.0,"EarningsPerShareBasic_1_FY_USD":0.4,"EarningsPerShareBasic_4_FY_USD":1.06,"EarningsPerShareDiluted_1_FY_USD":0.39,"EarningsPerShareDiluted_4_FY_USD":1.04,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":844942000.0,"NetIncomeLoss_1_FY_USD":100684000.0,"NetIncomeLoss_4_FY_USD":263484000.0,"StockholdersEquity_0_FY_USD":2028579000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":256804000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":253225000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":251557000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":248858000.0,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20180215"}]